OOIR: Observatory of International Research

Papers

(The H4-Index of Gut Microbes is 54. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Interactions and substrate selectivity within the SctRST complex of the type III secretion system of enteropathogenic Escherichia coli	241
Linking serum vitamin D levels with gut microbiota after 1-year lifestyle intervention with Mediterranean diet in patients with obesity and metabolic syndrome: a nested cross-sectional and prospective	209
Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity	203
L. rhamnosus CNCM I-3690 survival, adaptation, and small bowel microbiome impact in human	194
Opioid-induced dysbiosis of maternal gut microbiota during gestation alters offspring gut microbiota and pain sensitivity	160
Modeling spatial interaction networks of the gut microbiota	149
Prolonged oral antimicrobial administration prevents doxorubicin-induced loss of active intestinal stem cells	140
Antigenic operon fragmentation and diversification mechanism in Bacteroidota impacts gut metagenomics and pathobionts in Crohn's disease microlesions	114
Human milk oligosaccharide metabolism and antibiotic resistance in early gut colonizers: insights from bifidobacteria and lactobacilli in the maternal-infant microbiome	114
Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice	104
Effect of diet on the evolution of gut commensal bacteria	101
Akkermansia muciniphila reduces susceptibility to Listeria monocytogenes infection in mice fed a high-fat diet	94
Pasteurized Akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice	93
Progress of linking gut microbiota and musculoskeletal health: casualty, mechanisms, and translational values	93
3'-Sialyllactose and B. infantis synergistically alleviate gut inflammation and barrier dysfunction by enriching cross-feeding bacteria for short-chain fatty acid biosyn	91
Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PD	89
Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment	86
Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency	86
A high fiber diet or supplementation with Lactococcus lactis subspecies cremoris to pregnant mice confers protection against intestinal injury in adult offspring	81
Dietary fiber-based regulation of bile salt hydrolase activity in the gut microbiota and its relevance to human disease	79
The gut-joint axis mediates the TNF-induced RA process and PBMT therapeutic effects through the metabolites of gut microbiota	76
Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression	75
Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation	73
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome	73
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection	73

Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation	72
Intestinal bacteria and colorectal cancer: etiology and treatment	72
Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis	70
Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion	69
Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase	69
Microbiota during pregnancy and early life: role in maternal−neonatal outcomes based on human evidence	68
The Fe-S cluster biosynthesis in Enterococcus faecium is essential for anaerobic growth and gastrointestinal colonization	67
MS-20 enhances the gut microbiota-associated antitumor effects of anti-PD1 antibody	67
The microbiota and the host organism switch between cooperation and competition based on dietary iron levels	67
The crystal structure of the toxin EspC from enteropathogenic Escherichia coli reveals the mechanism that governs host cell entry and cytotoxicity	66
Citrobacter rodentium possesses a functional type II secretion system necessary for successful host infection	65
Gut microbiota drives structural variation of exogenous probiotics to enhance colonization	65
Gut microbiome diversity, variability, and latent community types compared with shifts in body weight during the freshman year of college in dormitory-housed adolescents	65
Mucus-penetrating microbiota drive chronic low-grade intestinal inflammation and metabolic dysregulation	62
Long COVID and gut microbiome: insights into pathogenesis and therapeutics	62
High throughput genome scale modeling predicts microbial vitamin requirements contribute to gut microbiome community structure	60
Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC	60
Gluten-free diet affects fecal small non-coding RNA profiles and microbiome composition in celiac disease supporting a host-gut microbiota crosstalk	60
Comparison of gnotobiotic communities reveals milk-adapted metabolic functions and unexpected amino acid metabolism by the pre-weaning microbiome	60
Multi-strain probiotics during pregnancy in women with obesity influence infant gut microbiome development: results from a randomized, double-blind placebo-controlled study	59
Engineered bacteria as an orally administered anti-viral treatment and immunization system	59
Dysbiotic but nonpathogenic shift in the fecal mycobiota of patients with rheumatoid arthritis	58
Communication between the gut microbiota and peripheral nervous system in health and chronic disease	57
Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection	57
The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential	56
Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy	56
The intestinal microbiome of inflammatory bowel disease across the pediatric age range	56
Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease	55
Gut microbiota-mediated conversion of mangiferin to norathyriol alters short chain fatty acid and urate metabolism	55
The regulatory effect of chitooligosaccharides on islet inflammation in T2D individuals after islet cell transplantation: the mechanism behind Candida albicans abundance	54
Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review	54
Gut virome profiling identifies an association between temperate phages and colorectal cancer promoted by Helicobacter pylori infection	54
Acids produced by lactobacilli inhibit the growth of commensal Lachnospiraceae and S24-7 bacteria	54